It is well known that IL-8, a chemokine that promotes neutrophil recruitment by increasing PMN both in the tumor microenvironment and in the periphery, has been linked to a poor prognosis in patients with GBM (Liang et al. 2014). The gene discussed is CXCL8; the disease is neoplasm.